Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


An implantable device could enable injection-free control of diabetes

Written by | 19 Sep 2023

One promising approach to treating Type 1 diabetes is implanting pancreatic islet cells that can produce insulin when needed, which can free patients from giving themselves frequent insulin… read more.

“Night Owls” at greater risk of diabetes

Written by | 16 Sep 2023

Persons with an evening ‘chronotype”’ (going to bed late and waking up late), have a 19 percent increased risk of diabetes compared to those with a morning chronotype,… read more.

Drinking kombucha may reduce blood sugar levels in people with type-two diabetes

Written by | 5 Aug 2023

People with type-II diabetes who drank the fermented tea drink kombucha for four weeks had lower fasting blood glucose levels compared to when they consumed a similar-tasting placebo… read more.

Global diabetes cases to soar from 529 million to 1.3 billion by 2050

Written by | 28 Jun 2023

More than half a billion people are living with diabetes worldwide, affecting men, women, and children of all ages in every country, and that number is projected to… read more.

FDA approves Jardiance for the treatment of type 2 diabetes in children 10 years and older – Boehringer Ingelheim + Eli Lilly

Written by | 27 Jun 2023

The FDA has approved Jardiance (empagliflozin) 10 mg and 25 mg tablets to lower blood sugar along with diet and exercise in children 10 years and older with… read more.

People who develop diabetes after pregnancy are less likely to regain control of blood sugar if they had gestational diabetes

Written by | 26 Jun 2023

People who develop diabetes following pregnancy were significantly less likely to be able to bring it under control if they had experienced gestational diabetes during their pregnancy, especially… read more.

Pharmacy researcher develops intervention for metabolic diseases like diabetes, stroke and heart disease

Written by | 24 Jun 2023

An investigator with the University of Kansas School of Pharmacy has filed an invention disclosure, part of a provisional patent application with the United States Patent and Trademark… read more.

One third of patients with diabetes in Austria discontinue treatment

Written by | 8 Jun 2023

A research team led by the Complexity Science Hub Vienna and the Medical University of Vienna has analysed the actual prevalence of Type 2 diabetes in Austria for… read more.

Tadalafil shows potential as a diabetes treatment

Written by | 17 May 2023

In a small feasibility study, subjects with type 2 diabetes achieved significant improvement in long-term blood sugar levels following treatment with high-dose tadalafil, an erectile dysfunction drug.  Tadalafil… read more.

Semaglutide for obesity treatment

Written by | 13 May 2023

Alex Miras is Professor of Endocrinology at the University of Ulster, UK and is an expert in obesity management and research. In 2021 a trial of semaglutide for… read more.

Could semaglutide prevent cardiometabolic disease?

Written by | 12 May 2023

Professor Alex Miras, consultant endocrinologist at the University of Ulster, takes the view that obesity is a disease. He explains why this is and how the SELECT trial… read more.

Do I need semaglutide and how can I get it?

Written by | 11 May 2023

Semaglutide works well on its own as obesity treatment but it works even better with the support and guidance of a multi-disciplinary weight-management team, according to Alex Miras,… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.